Shimon Ilan
Institute of Endocrinology, Rabin Medical Center- Beilinson Hospital, 39 Jabotinksi St, Petach Tikva, 4941492, Israel.
Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Rev Endocr Metab Disord. 2024 Dec;25(6):1041-1046. doi: 10.1007/s11154-024-09902-z. Epub 2024 Oct 2.
Prolactin deficiency is rare. It generally occurs when pituitary disorders, such as large pituitary tumors, pituitary apoplexy, and other conditions associated with sellar mass effect lead to global failure of pituitary function and hypopituitarism. In these situiations, prolactin is commonly the last pituitary hormone affected, after growth hormone and gonadotropins are lost and thyroid-stimulating hormone and adrenocorticotopic hormone secretion is impaired. Prolactin deficiency accompanies several congenital syndromes due to mutations in PROP1 and Pit1/ POU1F and in X-linked IGSF1 deficiency syndrome, and several aqcuired conditions including Sheehan syndrome, IgG4-related hypophysitis, and immune checkpoint-inhibitor-induced hypophysitis. In women, prolactin deficiency prevents lactation following childbirth among other symptoms associated with hypopituitarism. Human prolactin is not available commercially as replacement therapy. However, recombinant human prolactin administered daily to women with hypoprolactinemia and alactogenesis was found to lead to the production of significant milk volume sufficient for lactation.
催乳素缺乏症较为罕见。它通常发生在垂体疾病时,如大型垂体肿瘤、垂体卒中以及其他与鞍区占位效应相关的病症导致垂体功能全面衰竭和垂体功能减退。在这些情况下,催乳素通常是最后受到影响的垂体激素,此前生长激素和促性腺激素已丧失,促甲状腺激素和促肾上腺皮质激素的分泌也已受损。催乳素缺乏症伴随着多种先天性综合征,这是由于PROP1和Pit1/POU1F基因发生突变以及X连锁IGSF1缺乏综合征所致,同时也伴随着一些后天性病症,包括希恩综合征、IgG4相关性垂体炎以及免疫检查点抑制剂诱导的垂体炎。在女性中,催乳素缺乏症除了导致与垂体功能减退相关的其他症状外,还会妨碍产后泌乳。目前尚无市售的人催乳素用于替代疗法。然而,对患有低催乳素血症和无乳症的女性每天注射重组人催乳素后,发现可产生足够用于泌乳的大量乳汁。